This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy
Cell and gene therapy

Cell & Gene Therapy Manufacturing & Commercialization US Post Event Report

Posted by on 01 November 2021
Share this article

In September 2021, Cell and Gene Therapy Manufacturing & Commercialization US returned for the first time as a hybrid conference.

Co-located with BioProcess International, the event spanned across seven days, welcoming audiences in Boston and online, with tracks exploring:

  • Cell Therapy
  • Gene Edited Ex Vivo Cell Therapy
  • In Vivo Gene Therapy
  • Partnering & Collaborations
  • Tissue Engineering

In this post-event report in association with Avantor, we gather a collection of highlights from the week, including top presentations, a key panel discussion, poster and a spotlight session to watch on demand.

Click the image below or here to explore the report, or download a PDF version using the 'Download Now' link at the top of the page.

Share this article